Table 1 Characteristics of included patients from COHERE 2010–2014 and EuroSIDA 2001–2016
All n (% of all)a | Late presenters n (% of LP)b | |
|---|---|---|
Total number of people included | 39,204 (100) | 18,967 (48.4) |
Mode of infection | ||
Sex between men | 20,061 (51.2) | 7712 (38.4) |
Sex between men and women - men | 6262 (16.0) | 3915 (62.5) |
Sex between men and women - women | 6400 (16.3) | 3529 (55.1) |
Injecting drug use - men | 1293 (3.3) | 753 (58.2) |
Injecting drug use - men | 401 (1.0) | 165 (41.2) |
Men other | 3304 (8.4) | 2006 (60.7) |
Women other | 1483 (3.8) | 887 (59.8) |
Region of residence | ||
West | 38,511 (98.2) | 18,629 (48.4) |
Central (EuroSIDA only) | 179 (0.5) | 115 (64.2) |
East (EuroSIDA only) | 514 (1.3) | 223 (43.4) |
Region of birth | ||
Europe | 25,746 (65.0) | 11,773 (46.2) |
Africa | 3666 (9.4) | 2345 (64.0) |
Other | 3670 (9.4) | 2005 (54.6) |
Unknown | 6392 (16.3) | 2844 (44.5) |
Cohort | ||
COHERE 2010–2014 | 38,511 (98.2) | 18,629 (48.4) |
EuroSIDA 2001–2016 | 693 (1.8) | 338 (48.8) |
median (IQR) | median (IQR) | |
Age (years) | 37 (29–45) | 39 (32–48) |
CD4 cell count at entry into COHERE/EuroSIDA (/mm3) | 365 (186–553) | 180 (70–272) |
Baseline† (month/year) | 10/2011 (11/2010–11/2012) | 09/2011 (11/2010–11/2012) |